David Erritzøe (David Erritzoe, D Erritzoe)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 49

Top Topics

Depressive Symptoms

Top Venues

Journal of psychopharmacology (Oxford, England)

Scientific reports

Proceedings of the National Academy of Sciences of the United States of America

Acta psychiatrica Scandinavica

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph M Peill, Miriam Marguilho, David Erritzøe, Tommaso Barba, Kyle T Greenway, Fernando Rosas, Christopher Timmermann, Robin Lester Carhart-Harris
Psychedelics and the 'inner healer': Myth or mechanism? Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
David Erritzøe, Tommaso Barba, Meg J Spriggs, Fernando E Rosas, David J Nutt, Robin Lester Carhart-Harris
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression. Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Christopher Timmermann, Richard J Zeifman, David Erritzøe, David J Nutt, Robin L Carhart-Harris
Effects of DMT on mental health outcomes in healthy volunteers. Scientific reports 14 (1) (2024)
Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M Peill, Leor Roseman, David J Nutt, David Erritzøe, Robin Carhart-Harris, Bruna Giribaldi
Psychedelics and sexual functioning: a mixed-methods study. Scientific reports 14 (1) (2024)
Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M Peill, Leor Roseman, David J Nutt, David Erritzøe, Robin Carhart-Harris, Bruna Giribaldi
Psychedelics and sexual functioning: a mixed-methods study. Scientific reports 14 (1) (2024)
Jessica Barbut Siva, Tommaso Barba, Hannes S Kettner, Joanna Kuc, David J Nutt, Robin Lester Carhart-Harris, David Erritzøe
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. Journal of psychopharmacology (Oxford, England) 38 (2) (2024)
Joseph M Peill, Miriam Marguilho, David Erritzøe, Tommaso Barba, Kyle T Greenway, Fernando Rosas, Christopher Timmermann, Robin Lester Carhart-Harris
Psychedelics and the 'inner healer': Myth or mechanism? Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Christopher Timmermann, Richard J Zeifman, David Erritzøe, David J Nutt, Robin L Carhart-Harris
Effects of DMT on mental health outcomes in healthy volunteers. Scientific reports 14 (1) (2024)
Christopher Timmermann, Richard J Zeifman, David Erritzøe, David J Nutt, Robin L Carhart-Harris
Effects of DMT on mental health outcomes in healthy volunteers. Scientific reports 14 (1) (2024)
Alessia Marrocu, Hannes S Kettner, Brandon Weiss, Richard J Zeifman, David Erritzøe, Robin Lester Carhart-Harris
Psychiatric risks for worsened mental health after psychedelic use. Journal of psychopharmacology (Oxford, England) 38 (3) (2024)
Jessica Barbut Siva, Tommaso Barba, Hannes S Kettner, Joanna Kuc, David J Nutt, Robin Lester Carhart-Harris, David Erritzøe
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. Journal of psychopharmacology (Oxford, England) 38 (2) (2024)
Alessia Marrocu, Hannes S Kettner, Brandon Weiss, Richard J Zeifman, David Erritzøe, Robin Lester Carhart-Harris
Psychiatric risks for worsened mental health after psychedelic use. Journal of psychopharmacology (Oxford, England) 38 (3) (2024)
Alessia Marrocu, Hannes S Kettner, Brandon Weiss, Richard J Zeifman, David Erritzøe, Robin Lester Carhart-Harris
Psychiatric risks for worsened mental health after psychedelic use. Journal of psychopharmacology (Oxford, England) 38 (3) (2024)
Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M Peill, Leor Roseman, David J Nutt, David Erritzøe, Robin Carhart-Harris, Bruna Giribaldi
Psychedelics and sexual functioning: a mixed-methods study. Scientific reports 14 (1) (2024)
Joseph M Peill, Miriam Marguilho, David Erritzøe, Tommaso Barba, Kyle T Greenway, Fernando Rosas, Christopher Timmermann, Robin Lester Carhart-Harris
Psychedelics and the 'inner healer': Myth or mechanism? Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Jessica Barbut Siva, Tommaso Barba, Hannes S Kettner, Joanna Kuc, David J Nutt, Robin Lester Carhart-Harris, David Erritzøe
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. Journal of psychopharmacology (Oxford, England) 38 (2) (2024)
Joseph M Peill, Miriam Marguilho, David Erritzøe, Tommaso Barba, Kyle T Greenway, Fernando Rosas, Christopher Timmermann, Robin Lester Carhart-Harris
Psychedelics and the 'inner healer': Myth or mechanism? Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
David Erritzøe, Tommaso Barba, Meg J Spriggs, Fernando E Rosas, David J Nutt, Robin Lester Carhart-Harris
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression. Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Alessia Marrocu, Hannes S Kettner, Brandon Weiss, Richard J Zeifman, David Erritzøe, Robin Lester Carhart-Harris
Psychiatric risks for worsened mental health after psychedelic use. Journal of psychopharmacology (Oxford, England) 38 (3) (2024)
David Erritzøe, Tommaso Barba, Meg J Spriggs, Fernando E Rosas, David J Nutt, Robin Lester Carhart-Harris
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression. Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
David Erritzøe, Tommaso Barba, Meg J Spriggs, Fernando E Rosas, David J Nutt, Robin Lester Carhart-Harris
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression. Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Jessica Barbut Siva, Tommaso Barba, Hannes S Kettner, Joanna Kuc, David J Nutt, Robin Lester Carhart-Harris, David Erritzøe
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. Journal of psychopharmacology (Oxford, England) (2024)
Jessica Barbut Siva, Tommaso Barba, Hannes S Kettner, Joanna Kuc, David J Nutt, Robin Lester Carhart-Harris, David Erritzøe
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. Journal of psychopharmacology (Oxford, England) 38 (2) (2024)
Joseph M Peill, Miriam Marguilho, David Erritzøe, Tommaso Barba, Kyle T Greenway, Fernando Rosas, Christopher Timmermann, Robin Lester Carhart-Harris
Psychedelics and the 'inner healer': Myth or mechanism? Journal of psychopharmacology (Oxford, England) (2024)
Christopher Timmermann, Richard J Zeifman, David Erritzøe, David J Nutt, Robin L Carhart-Harris
Effects of DMT on mental health outcomes in healthy volunteers. Scientific reports 14 (1) (2024)
Alessia Marrocu, Hannes S Kettner, Brandon Weiss, Richard J Zeifman, David Erritzøe, Robin Lester Carhart-Harris
Psychiatric risks for worsened mental health after psychedelic use. Journal of psychopharmacology (Oxford, England) 38 (3) (2024)
Christopher Timmermann, Richard J Zeifman, David Erritzøe, David J Nutt, Robin L Carhart-Harris
Effects of DMT on mental health outcomes in healthy volunteers. Scientific reports 14 (1) (2024)
David Erritzøe, Tommaso Barba, Meg J Spriggs, Fernando E Rosas, David J Nutt, Robin Lester Carhart-Harris
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression. Journal of psychopharmacology (Oxford, England) (2024)
Jessica Barbut Siva, Tommaso Barba, Hannes S Kettner, Joanna Kuc, David J Nutt, Robin Lester Carhart-Harris, David Erritzøe
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. Journal of psychopharmacology (Oxford, England) 38 (2) (2024)
Brandon Weiss, Aleksandra Wingert, David Erritzøe, W Keith Campbell
Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca. Scientific reports 13 (1) (2023)
Matthew B Wall, Rebecca Harding, Rayyan Zafar, Eugenii A Rabiner, David John Nutt, David Erritzøe
Neuroimaging in psychedelic drug development: past, present, and future. Molecular psychiatry (2023)
Christopher Timmermann, Leor Roseman, Sharad Haridas, Fernando E Rosas, Lisa Luan, Hannes Kettner, Jonny Martell, David Erritzøe, Enzo Tagliazucchi, Carla Pallavicini, Manesh Girn, Andrea Alamia, Robert Leech, David John Nutt, Robin L Carhart-Harris
Human brain effects of DMT assessed via EEG-fMRI. Proceedings of the National Academy of Sciences of the United States of America 120 (13) (2023)
Brandon M Weiss, David Erritzøe, Bruna Giribaldi, David J Nutt, Robin Lester Carhart-Harris
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression. Journal of psychopharmacology (Oxford, England) (2023)
Rebecka Bremler, Nancy Katati, Parvinder Shergill, David Erritzøe, Robin L Carhart-Harris
Case analysis of long-term negative psychological responses to psychedelics. Scientific reports 13 (1) (2023)
Richard J Zeifman, Hannes Kettner, Broc A Pagni, Austin Mallard, Daniel E Roberts, David Erritzøe, Stephen Ross, Robin L Carhart-Harris
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences. Scientific reports 13 (1) (2023)
Lisa X Luan, Emma Eckernäs, Michael Ashton, Fernando E Rosas, Malin V Uthaug, Alexander Bartha, Samantha Jagger, Kiara Gascon-Perai, Lauren Gomes, David J Nutt, David Erritzøe, Robin Lester Carhart-Harris, Christopher Timmermann
Psychological and physiological effects of extended DMT. Journal of psychopharmacology (Oxford, England) (2023)
Sameer Jauhar, Danilo Arnone, David S Baldwin, Michael A P Bloomfield, Michael Browning, Anthony J Cleare, Philip Robert Corlett, John Francis William Deakin, David Erritzøe, Cynthia H Y Fu, Paolo Fusar-Poli, Guy M Goodwin, Joseph Hayes, Robert Howard, Oliver D Howes, Mário Francisco Juruena, Raymond W Lam, Stephen M Lawrie, Hamish McAllister-Williams, Steven Marwaha, David Matuskey, Robert A McCutcheon, David John Nutt, Carmine Maria Pariante, Toby Pillinger, Rajiv Radhakrishnan, James J H Rucker, Sudhakar Selvaraj, Paul Stokes, Rachel Upthegrove, Nefize Yalin, Lakshmi Yatham, Allan H Young, Roland Zahn, Philip J Cowen
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Molecular psychiatry (2023)
Christopher Timmermann, Leor Roseman, Sharad Haridas, Fernando E Rosas, Lisa Luan, Hannes Kettner, Jonny Martell, David Erritzøe, Enzo Tagliazucchi, Carla Pallavicini, Manesh Girn, Andrea Alamia, Robert Leech, David John Nutt, Robin L Carhart-Harris
Human brain effects of DMT assessed via EEG-fMRI. Proceedings of the National Academy of Sciences of the United States of America 120 (13) (2023)
Meg J Spriggs, Bruna Giribaldi, Taylor Lyons, Fernando E Rosas, Laura S Kärtner, Tobias Buchborn, Hannah M Douglass, Leor Roseman, Christopher Timmermann, David Erritzøe, David J Nutt, Robin Lester Carhart-Harris
Body mass index (BMI) does not predict responses to psilocybin. Journal of psychopharmacology (Oxford, England) (2022)
Victoria Amalie Nygart, Lis Marie Pommerencke, Eline Haijen, Hannes S Kettner, Mendel Kaelen, Erik Lykke Mortensen, David John Nutt, Robin Lester Carhart-Harris, David Erritzøe
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample. Journal of psychopharmacology (Oxford, England) 36 (8) (2022)
Robin Lester Carhart-Harris, Anne C Wagner, Manish Agrawal, Hannes S Kettner, Jerold F Rosenbaum, Adam Gazzaley, David J Nutt, David Erritzøe
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine? Journal of psychopharmacology (Oxford, England) (2021)
Pedro J Teixeira, Matthew W Johnson, Christopher Timmermann, Rosalind Watts, David Erritzøe, Hannah Douglass, Hannes S Kettner, Robin Lester Carhart-Harris
Psychedelics and health behaviour change. Journal of psychopharmacology (Oxford, England) (2021)
Kristoffer A A Andersen, Robin Lester Carhart-Harris, David John Nutt, David Erritzøe
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta psychiatrica Scandinavica 143 (2) (2020)
Dea Siggaard Stenbaek, Martin Korsbak Madsen, Brice Ozenne, Sara Kristiansen, Daniel Burmester, David Erritzøe, Gitte Moos Knudsen, Patrick MacDonald Fisher
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans. Journal of psychopharmacology (Oxford, England) 35 (4) (2020)
Anya Borissova, Bart Ferguson, Matthew B Wall, Celia Ja Morgan, Robin Lester Carhart-Harris, Mark Bolstridge, Michael A P Bloomfield, Tim M Williams, Amanda Feilding, Kevin Murphy, Robin J Tyacke, David Erritzøe, Lorna Stewart, Kim Wolff, David Nutt, H Valerie Curran, Will Lawn
Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. Journal of psychopharmacology (Oxford, England) 35 (5) (2020)
David Erritzøe, Abhishekh H Ashok, Graham E Searle, Alessandro Colasanti, Samuel Turton, Yvonne Lewis, Mickael Huiban, Sara Moz, Jan Passchier, Azeem Saleem, John Beaver, Anne Lingford-Hughes, David John Nutt, Oliver D Howes, Roger N Gunn, Gitte M Knudsen, Eugenii A Rabiner
Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (5) (2019)
David Erritzøe, James Smith, Patrick M Fisher, Robin Lester Carhart-Harris, Vibe G Frokjaer, Gitte M Knudsen
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers. Journal of psychopharmacology (Oxford, England) 33 (9) (2019)
Christopher Timmermann, Leor Roseman, Michael Schartner, Raphaël Millière, Luke T J Williams, David Erritzøe, Suresh Muthukumaraswamy, Michael Ashton, Adam Bendrioua, Okdeep Kaur, Samuel Turton, Matthew M Nour, Camilla M Day, Robert Leech, David J Nutt, Robin L Carhart-Harris
Neural correlates of the DMT experience assessed with multivariate EEG. Scientific reports 9 (1) (2019)
David Erritzøe, L Roseman, M M Nour, K MacLean, M Kaelen, D J Nutt, R L Carhart-Harris
Effects of psilocybin therapy on personality structure. Acta psychiatrica Scandinavica 138 (5) (2018)